Regulators Order Illumina Merger Target Grail to Stay Separate While Awaiting End to Inquiry - NewsBreak

BRUSSELS – The European Commission said Friday it had taken interim measures in Illumina's acquisition of cancer detection test maker Grail Inc., including an order that Grail be kept separate. Illumina, the San Diego-based gene-sequencing company, announced on Aug...